卡伯戈林治疗手术前的非功能性垂体腺瘤
Irit Ayalon-Dangur1,2, Adi Turjeman2,3, Dania Hirsch1,2
1Institute of Endocrinology, Beilinson Hospital, Rabin Medical Center, Beilinson Campus, Petah Tikva, 49100, Israel.
Pituitary
|December 8, 2023
概括
卡伯戈林在某些患者中显示出作为非功能性垂体腺瘤 (NFPAs) 的首要治疗方法的潜力. 这项研究发现,卡贝戈林在许多患者中稳定或减少瘤大小,这表明它在控制NFPAs方面的有效性.
科学领域:
- 内分泌学 在内分泌学.
- 神经外科 神经外科
- 在瘤学瘤学.
背景情况:
- 非功能性垂体腺瘤 (NFPAs) 通常通过手术,放射,药物或观察来治疗.
- 卡伯戈林是一种多巴胺激动剂,已经在手术后探索了残留NFPAs.
- 这项研究评估了cabergoline作为NFPAs初始治疗的有效性.
研究的目的:
- 研究卡伯戈林作为非功能性垂体腺瘤 (NFPAs) 的未经手术治疗的患者的主要治疗方法的疗效.
主要方法:
- 一项回顾性队列研究包括25名手术前未经手术治疗的NFPA (≥10毫米) 患者.
- 患者接受卡贝戈林 (≥1毫克/周) 至少24个月;那些患有骨损伤的人被排除在外.
- 瘤大小变化 (收缩或生长≥2毫米) 通过MRI评估,以及症状和荷尔蒙数据.
主要成果:
- 25名患者接受了卡伯戈林作为主要治疗,平均随访时间为4.6年.
- 瘤大小减少了20% (5/25),在48% (12/25) 保持稳定,并在32% (8/25) 增加.
- 瘤扩大与更大的初始腺瘤大小和更长的随访相关;两名患者需要手术.
结论:
- 对于精心挑选的非功能性垂体腺瘤患者来说,初级卡伯戈林治疗是一种可行的选择.
- 这种方法对NFPA特别适合,在NFPA中没有立即威胁到视力.
相关概念视频
Parkinson's Disease: Treatment
274
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
274
Direct-Acting Cholinergic Agonists: Therapeutic Uses
748
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
748
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
336
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
336
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.2K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.2K
Open Angle Glaucoma: Treatment
455
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
455


